World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Immunology
USA
2026

D-Index & Metrics

Best Scientists

D-Index
171
Citations
112179
World Ranking
838
National Ranking
503

Immunology

D-Index
174
Citations
115277
World Ranking
46
National Ranking
33

Medicine

D-Index
175
Citations
115462
World Ranking
435
National Ranking
262

Jeffrey A. Bluestone publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jeffrey A. Bluestone sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 541 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jeffrey A. Bluestone D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey A. Bluestone sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 174 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in United States Leader Award
  • 2020 - AAI Excellence in Mentoring Award, American Association of Immunologists
  • 2019 - Distinguished Fellows of the American Association of Immunologists (AAI)
  • 2013 - Member of the National Academy of Medicine (NAM)
  • 2006 - Fellow of the American Academy of Arts and Sciences
  • 1997 - Fellow of John Simon Guggenheim Memorial Foundation

Overview

Jeffrey A. Bluestone is affiliated with the University of California, San Francisco in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on Immunology, Oncology, Genetics, Molecular Biology, and Endocrinology, Diabetes and Metabolism.

The scientist's work covers various main topics, including:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • Diabetes and associated disorders
  • Cancer Immunotherapy and Biomarkers
  • Pancreatic function and diabetes
  • Diabetes Management and Research

Frequent co-authors in their publications include:

  • Qizhi Tang
  • Arabella Young
  • Shen Dong
  • Kevan C. Herold
  • Patrick Ho

Key recent papers authored or co-authored by Bluestone are:

  • Multiple early factors anticipate post-acute COVID-19 sequelae, 2022, Cell
  • Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19, 2020, Cell
  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials, 2020, The Lancet
  • Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis, 2020, Science Immunology
  • CRISPR screen in regulatory T cells reveals modulators of Foxp3, 2020, Nature

Bluestone's frequent publication venues include:

  • The Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Cell
  • Nature Immunology

Awards and recognitions received by Bluestone are:

  • AAI Excellence in Mentoring Award, American Association of Immunologists, 2020
  • Distinguished Fellow of the American Association of Immunologists (AAI), 2019
  • Member of the National Academy of Medicine (NAM), 2013
  • Fellow of the American Academy of Arts and Sciences, 2006
  • Fellow of John Simon Guggenheim Memorial Foundation, 1997

Best Publications

  • Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

    E A Tivol;F Borriello;A N Schweitzer;W P Lynch

  • CD28/B7 SYSTEM OF T CELL COSTIMULATION

    Deborah J. Lenschow;Theresa L. Walunas;Jeffrey A. Bluestone

  • CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

    Weihong Liu;Amy L Putnam;Zhou Xu-yu;Gregory L. Szot

  • CTLA-4 can function as a negative regulator of T cell activation

    Theresa L. Walunas;Deborah J. Lenschow;Christina Y. Bakker;Peter S. Linsley

  • B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

    Benoît Salomon;Deborah J Lenschow;Lesley Rhee;Neda Ashourian

  • International Trial of the Edmonton Protocol for Islet Transplantation

    A. M James Shapiro;Camillo Ricordi;Bernhard J. Hering;Hugh Auchincloss

  • Innate immunity and intestinal microbiota in the development of Type 1 diabetes

    Li Wen;Ruth E. Ley;Ruth E. Ley;Pavel Yu. Volchkov;Peter B. Stranges

  • Identification of a monoclonal antibody specific for a murine T3 polypeptide

    Oberdan Leo;Michele Foo;David H. Sachs;Lawrence E. Samelson

  • Natural versus adaptive regulatory T cells.

    Jeffrey A. Bluestone;Abul K. Abbas

  • The B7 and CD28 receptor families

    Carl H. June;Jeffrey A. Bluestone;Lee M. Nadler;Craig B. Thompson

  • Genetics, pathogenesis and clinical interventions in type 1 diabetes

    Jeffrey A. Bluestone;Kevan Herold;George Eisenbarth

  • Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

    Xuyu Zhou;Samantha L Bailey-Bucktrout;Lukas T Jeker;Cristina Penaranda

  • Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg

    DJ Lenschow;Y Zeng;Thistlethwaite;A Montag

  • In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes

    Qizhi Tang;Kammi J. Henriksen;Mingying Bi;Erik B. Finger

  • Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

    Kevan C. Herold;William Hagopian;Julie A. Auger;Ena Poumian-Ruiz

  • Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation

    Benoît Salomon;Jeffrey A. Bluestone

  • THE NOD MOUSE: A Model of Immune Dysregulation

    Mark S. Anderson;Jeffrey A. Bluestone

  • Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis.

    Noriko Komatsu;Kazuo Okamoto;Shinichiro Sawa;Tomoki Nakashima

  • The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.

    Qizhi Tang;Jeffrey A Bluestone

  • Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

    Brian T. Fife;Jeffrey A. Bluestone

Frequent Co-Authors

Qizhi Tang
Qizhi Tang University of California, San Francisco
Kevan C. Herold
Kevan C. Herold Yale University
David H. Sachs
David H. Sachs Columbia University
Anne I. Sperling
Anne I. Sperling University of Virginia
Craig B. Thompson
Craig B. Thompson Memorial Sloan Kettering Cancer Center
Maria-Luisa Alegre
Maria-Luisa Alegre University of Chicago
Todd M. Brusko
Todd M. Brusko University of Florida
Stephen D. Miller
Stephen D. Miller Northwestern University
Alexander Marson
Alexander Marson University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing healthcare degrees with a focus on nursing and specialized practice offers valuable career opportunities. Many students explore programs with streamlined admissions, such as lpn programs with easiest admission requirements, which provide a solid foundation in patient care while allowing quicker entry into the workforce.

Advancing beyond LPN, becoming a Nurse Practitioner is a popular route. Programs known as the easiest nurse practitioner program offer accessible pathways for those looking to deepen their clinical skills and specialize in areas relevant to immunology and patient immune response management.

For nurses interested in mental health, the best pmhnp programs online combine convenience with strong clinical placements. This is crucial for gaining hands-on experience in psychiatric and mental health nursing within an immunology-related context.

Cost is a significant factor for many students. Fortunately, there are options like the cheapest psych np programs online, which make pursuing a psychiatric nurse practitioner degree more financially feasible without sacrificing quality.

Best Scientists Citing Jeffrey A. Bluestone

Trending Scientists

Recently Published Articles